X T L Biopharmaceuticals reported $-479K in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Bioline Rx USD -673K 2.99M Sep/2025
Teva Pharmaceutical Industries USD 758M 181M Mar/2026
X T L Biopharmaceuticals USD -479K 19K Dec/2024